Cell Metabolism
Volume 31, Issue 5, 5 May 2020, Pages 892-908.e11
Clinical and Translational ReportLow-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
sorafenib
nonalcoholic steatohepatitis (NASH)
AMP–activated protein kinase (AMPK)
mitochondrial uncoupler
Cited by (0)
© 2020 Elsevier Inc.